Host-Directed Therapies for Tackling Multi-Drug Resistant Tuberculosis: Learning From the Pasteur-Bechamp Debates

OA Location

https://academic.oup.com/cid/article-lookup/doi/10.1093/cid/civ631

Author(s)

Zumla, A

Maeurer, M

Chakaya, J

Hoelscher, M

Ntoumi, F

more

Type

Journal Article

Date Issued

2015-11-01

URI

http://hdl.handle.net/10044/1/51747

DOI

10.1093/cid/civ631

ISSN

1058-4838

Publisher

OXFORD UNIV PRESS INC

Start Page

1432

End Page

1438

Journal / Book Title

CLINICAL INFECTIOUS DISEASES

Volume

61

Issue

9

Identifier

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000362956000012&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Subjects

Science & Technology

Life Sciences & Biomedicine

Immunology

Infectious Diseases

Microbiology

host-directed therapy

tuberculosis

treatment

multi-drug resistant tuberculosis

repurposed drugs

SUB-SAHARAN AFRICA

DEVELOPING-COUNTRIES

PULMONARY TUBERCULOSIS

ADJUNCT THERAPIES

MOXIFLOXACIN

REGIMENS

TRIALS

DRUGS

OPPORTUNITIES

PARTNERSHIPS

Antitubercular Agents

Combined Modality Therapy

Humans

Mycobacterium tuberculosis

Precision Medicine

Time Factors

Tuberculosis, Multidrug-Resistant

Host-Directed Therapies Network (HDT-NET) Consortium

06 Biological Sciences

11 Medical And Health Sciences

Publication Status

Published